| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cost of Revenue | $2.4M | -66.6% |
| R&D Expense | $1.3M | -16.5% |
| SG&A Expense | $10.5M | -12.4% |
| Operating Income | -$23.3M | +2.2% |
| Pre-tax Income | -$22.6M | +7.8% |
| Income Tax | $2K | -33.3% |
| Net Income | -$22.6M | +7.8% |
| EPS (Basic) | -$15.15 | -295.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.8M | +165.0% |
| Inventory | $244K | -2.8% |
| Current Assets | $13.4M | +188.7% |
| Total Assets | $19.7M | -25.3% |
| Current Liabilities | $4.4M | -45.9% |
| Total Liabilities | $4.9M | -51.2% |
| Stockholders' Equity | $14.8M | -9.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.3M | +24.8% |
| Capital Expenditures | $425K | -94.6% |
| Investing Cash Flow | $2.9M | +124.9% |
| Financing Cash Flow | $14.1M | +9.8% |
| Free Cash Flow | -$10.7M | +50.5% |